1 / 24

Role of private pharmacies in TB control in Egypt, 2009

Role of private pharmacies in TB control in Egypt, 2009. Principal investigators Dr.Sherry Victor / NTP Logistic and DR-TB officer Dr. Magdy Fawzy/ Research & PAL coordinator, DR-TB consultant Technical assisstance: Dr Amal Bassili, TB Surveillance officer, STB/WHO/EMRO

chadmyers
Télécharger la présentation

Role of private pharmacies in TB control in Egypt, 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Role of private pharmacies in TB control in Egypt, 2009 Principal investigators Dr.Sherry Victor / NTP Logistic and DR-TB officer Dr. Magdy Fawzy/ Research & PAL coordinator, DR-TB consultant Technical assisstance: Dr Amal Bassili, TB Surveillance officer, STB/WHO/EMRO Focal point, Tropical Disease Research.

  2. Egyptis a country in North Africa Area:1,010,000 square kilometers Population : 79,000,000

  3. Objectives of the study: General objective: • To describe the current pattern of TB treatment regimens used in the private pharmacies in Egypt

  4. Specific objectives • To determine the proportion of private pharmacies that have anti-TB treatment, ATT, in different geographical governorates; • To evaluate the prescribing practices of the physicians referring cases to the private pharmacies for purchasing the drugs; • To evaluate knowledge, attitudes and practices, KAP, of the private pharmacists towards TB; • To evaluate the feasibility of engaging the private pharmacists in identifying TB suspects and their referral to the nearest TBMU for diagnosis.

  5. Study area/Govenorates • The study was carried out in a representative sample of all Egyptian governorates. • Inclusion criteria - Pharmacies that have been working for at least 3 months whether registered or not - Consent to participate in the study

  6. Study type • Cross-sectional survey conducted in one quarter where pharmacists/pharmacists assistants in a representative sample of private pharmacies were interviewed using a questionnaire inquiring the following information: • The presence of ATT, • Their KAP regarding TB, • Prescribing practices by the pharmacist (over the counter use of drugs), • The prescribing practices of the referring physicians, and the extent of their adherence to the NTP guidelines.

  7. Pharmacists were requested to identify and collect information about TB suspects visiting their pharmacies during the study period and to refer them to the nearest TB management unit, TBMU. • They were subjected to every other week visits by the field supervisors in each district in order to: • ensure the quality of data collected • collect the completed forms • send them to the NTP central unit

  8. Sample size • The district is the primary sampling unit for the study. • A sampling frame was developed from the list of pharmacies at the district level in the different governorates and 30 clusters in 20 governorates were selected using probability proportionate to size. • The final sample size was 960 pharmacies. • The cluster size was: 960/30= 32 pharmacy in each selected cluster. • Only 866 responded in 17 governorates (27 clusters)

  9. Methodology • Each district was covered by one pharmacist working at the governorates local authorities under the supervision of their heads. • One day orientation was carried (TB overview, how to choose the selected sample, questionnaire overview) • The study period was August, September and October 2009

  10. Interviewed personnel by gender

  11. Personnel by Job and Gender * Owners, directors and hired pharmacists

  12. Knowledge about NTP with age group

  13. Knowledge by governorate

  14. Source of knowledge *Highest knowledge was from mass media. ** Others: Pharmacies inspectors, Government obligatory duty after graduation.

  15. Willing to collaborate with NTP

  16. Suggested collaboration activities

  17. Collaboration barriers • 75% responded that there are no barriers • 19% mentioned that barriers could be time constraints, no cases being met, health status of the pharmacist, not the responsible personnel to decide……. • 6% didn’t respond

  18. Suggestions to strengthen notification to NTP • 44 % suggested hot line • 10% email address • 8 % others • 38% didn’t offer suggestions

  19. How the pharmacist deal with TB suspects

  20. Anti-TB medications sold during the study period

  21. TB treatment regimens prescribed for TB patients The referring sites were: • Public hospitals other than NTP units (minority) • Private hospitals and clinics (forming the highest percentage, 83%)

  22. Regimens prescribed • 446 regimen were prescribed: • 314 (70%) were mono-therapy either R, Z, E or S • 78 (17 %) were di-therapy mainly RH • 44 ( 10%) were treated with combination therapy. • 5 prescriptions (1%) were with Levofloxacin (Lfx) in addition to first line drugs.

  23. Recommendations • Orientation programs to pharmacists working in private sector concerning TB symptoms, and referral channels. • Hot line to NTP aiming at case notifications. • Distribution of IEC materials to the private sector. • Strengthening collaboration with private doctors. • Enhancing community orientation through mass media. • Activation of legislation that ban the selling of anti-TB drugs over the counter.

More Related